feyninc/tacha huggingface dataset:
## Table

|  | June 30, |  |  |
|---|---|---|---|
|  | 2019 | 2018 | Estimated Useful Life |
| Land (1) | $23,243 | $24,845 |  |
| Land improvements (1) | 25,209 | 25,383 | 5 - 20 years |
| Buildings (1) | 147,220 | 143,918 | 20 - 30 years |
| Leasehold improvements | 48,478 | 48,060 | 5 - 30 years(2) |
| Equipment and furniture | 365,101 | 328,864 | 3 - 10 years |
| Aircraft and equipment | 39,293 | 38,761 | 4 - 10 years |
| Construction in progress | 12,411 | 39,872 |  |
|  | 660,955 | 649,703 |  |
| Less accumulated depreciation | 388,481 | 364,153 |  |
| Property and equipment, net | $272,474 | $285,550 |  |



## Text

NOTE 3. PROPERTY AND EQUIPMENT


The classification of property and equipment, together with their estimated useful lives is as follows:


(1) Excludes assets held for sale


(2) Lesser of lease term or estimated useful life


The change in property and equipment in accrued liabilities was $14,315 and $15,674 for the fiscal years ended June 30, 2019 and 2018, respectively. These amounts were excluded from capital expenditures on the statements of cash flows.


No impairments of property and equipment were recorded in fiscal 2019 or 2018.


During the third quarter of fiscal 2019, the Company received an unsolicited offer to purchase its Houston, TX, facility. At June 30, 2019, the facility included assets with a carrying value of approximately $5,055. Although management has not committed to the sale, a sale of the facility during fiscal 2020 is likely and the Company expects to record a gain on the sale upon closing, since the offer represents full appraisal value for the facility. Therefore, the assets are considered held for sale at June 30, 2019. Also held for sale at June 30, 2019, was the Company’s Elizabethtown, KY facility. During the third quarter of fiscal 2018, the Company reached a definitive agreement to sell the property for $1,300 pending an expected closing date during the second quarter of fiscal 2020. An impairment loss was recorded on this facility during fiscal 2017 as disclosed in Note 2 to the Company’s consolidated financial statements. Total assets held for sale by the Company at June 30, 2019 and 2018 were $6,355 and $1,300, respectively, and were included in assets held for sale on the Company’s consolidated balance sheet for each year. Those balances are not included on the above table.
## Table

| (In millions, except percentages and per share amounts) | 2019 | 2018 | 2017 | Percentage Change 2019 Versus 2018 | Percentage Change 2018 Versus 2017 |
|---|---|---|---|---|---|
| Operating income | $42,959 | $35,058 | $  29,025 | 23% | 21% |
| Net tax impact of transfer of intangible properties | 0 | 0 | 0 | * | * |
| Net impact of the TCJA | 0 | 0 | 0 | * | * |
| Restructuring expenses | 0 | 0 | 306 | * | * |
| Non-GAAP operating income | $42,959 | $35,058 | $ 29,331 | 23% | 20% |
| Net income | $39,240 | $16,571 | $ 25,489 | 137% | (35)% |
| Net tax impact of transfer of intangible properties | (2,567) | 0 | 0 | * | * |
| Net tax impact of the TCJA | 157 | 13,696 | 0 |  |  |
| Restructuring expenses | 0 | 0 | 243 | * | * |
| Non-GAAP net income | $36,830 | $30,267 | $ 25,732 | 22% | 18% |
| Diluted earnings per share | $5.06 | $2.13 | $ 3.25 | 138% | (34)% |
| Net tax impact of transfer of intangible properties | (0.33) | 0 | 0 | * | * |
| Net tax impact of the TCJA | 0.02 | 1.75 | 0 | * | * |
| Restructuring expenses | 0 | 0 | 0.04 | * | * |
| Non-GAAP diluted earnings per share | $4.75 | $3.88 | $ 3.29 | 22% | 18% |
| * not meaningful |  |  |  |  |  |



## Text

NON-GAAP FINANCIAL MEASURES


Non-GAAP operating income, net income, and diluted EPS are non-GAAP financial measures which exclude the net tax impact of transfer of intangible properties, the net tax impact of the TCJA, and restructuring expenses. We believe these non-GAAP measures aid investors by providing additional insight into our operational performance and help clarify trends affecting our business. For comparability of reporting, management considers non-GAAP measures in conjunction with GAAP financial results in evaluating business performance. These non-GAAP financial measures presented should not be considered a substitute for, or superior to, the measures of financial performance prepared in accordance with GAAP.


The following table reconciles our financial results reported in accordance with GAAP to non-GAAP financial results:


* Not meaningful.
## Table

|  |  | 2019 | 2018 | 2017 |
|---|---|---|---|---|
|  | Notes | €m | €m | €m |
| (Loss)/profit for the financial year |  | (7,644) | 2,788 | (6,079) |
| Loss from discontinued operations | 7 | 3,535 | 1,969 | 4,107 |
| (Loss)/profit for the financial year from continuing operations |  | (4,109) | 4,757 | (1,972) |
| Non-operating expense |  | 7 | 32 | 1 |
| Investment income |  | (433) | (685) | (474) |
| Financing costs |  | 2,088 | 1,074 | 1,406 |
| Income tax expense/(credit) | 6 | 1,496 | (879) | 4,764 |
| Operating (loss)/profit |  | (951) | 4,299 | 3,725 |
| Adjustments for: |  |  |  |  |
| Share-based payments and other non-cash charges |  | 147 | 128 | 95 |
| Depreciation and amortisation | 10, 11 | 9,795 | 10,409 | 11,086 |
| Loss on disposal of property, plant and equipment and intangible assets | 3 | 33 | 36 | 22 |
| Share of result of equity accounted associates and joint ventures |  | 908 | 59 | (47) |
| Impairment losses | 4 | 3,525 | – | – |
| Other expense/(income) |  | 148 | (213) | (1,052) |
| (Increase)/decrease in inventory |  | (131) | (26) | 117 |
| (Increase)/decrease in trade and other receivables | 14 | (31) | (1,118) | 308 |
| Increase/(decrease) in trade and other payables | 15 | 739 | 286 | (473) |
| Cash generated by operations |  | 14,182 | 13,860 | 13,781 |
| Net tax paid |  | (1,131) | (1,118) | (761) |
| Cash flows from discontinued operations |  | (71) | 858 | 1,203 |
| Net cash flow from operating activities |  | 12,980 | 13,600 | 14,223 |



## Text

18. Reconciliation of net cash flow from operating activities


The table below shows how our (loss)/profit for the year from continuing operations translates into cash flows generated from our operating activities.
## Table

|  |  | 2019 | 2018 |
|---|---|---|---|
|  | Notes | $ million | $ million |
| Non-current trade and other receivables | 20 | 5.7 | 3.5 |
| Cash and cash equivalents | 22 | 183.2 | 121.6 |
| Current trade and other receivables | 20 | 133.2 | 126.9 |
| Current other financial assets | 20 | 0.1 | – |
| Financial assets |  | 322.2 | 252.0 |
| Non-current other payables, excluding government grants | 23 | 0.8 | 4.4 |
| Current trade payables, other payables and accruals | 23 | 75.4 | 57.1 |
| Lease liabilities, current and non-current | 26 | 33.0 | – |
| Contractual provisions | 28 | 3.6 | 3.6 |
| Financial liabilities |  | 112.8 | 65.1 |



## Text

30. Financial instruments and financial risk management


The main purpose of the Group’s financial instruments, other than trade and other receivables, trade and other payables, contractual provisions and lease liabilities, is to fund the Group’s liquidity requirements.


All of the Group’s financial assets and liabilities are categorised as financial assets/liabilities stated at amortised cost, except for forward foreign currency exchange contracts, included within current other financial assets, that are designated as financial assets at fair value through profit or loss and corporate owned life insurance, amounting to $3.0 million (2018 $2.4 million), included within non-current trade and other receivables, that is designated as financial assets at fair value through profit or loss. These are shown in the below table:


The Group enters into derivative transactions, forward foreign currency exchange contracts, for the management of the Group’s foreign currency exposures when deemed appropriate.


The key objective of the Group’s treasury department is to manage the financial risks of the business and to ensure that sufficient liquidity is available to the Group. All treasury activity operates within a formal control framework. The Board has approved treasury policies and guidelines and periodically reviews treasury activities. Additionally, it is the Group’s policy that speculative treasury transactions are expressly forbidden.
## Table

| (in thousands, except per share amounts) | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|
| Consolidated Statements of Operations Data (1) (2): |  |  |  |  |  |
| Revenue: |  |  |  |  |  |
| Perpetual license | $80,015 | 109,863 | 132,883 | 145,053 | 166,305 |
| Term license | 199,433 | 178,256 | 206,411 | 152,231 | 109,283 |
| Maintenance | 280,580 | 263,875 | 242,320 | 218,635 | 202,802 |
| Cloud | 133,746 | 82,627 | 51,097 | 40,647 | 30,626 |
| Consulting | 217,609 | 256,960 | 255,756 | 205,663 | 173,679 |
| Total revenue | $911,383 | 891,581 | 888,467 | 762,229 | 682,695 |
| (Loss) income from operations | $(134,878) | $(17,032) | $93,177 | $50,644 | $64,661 |
| Net (loss) income | $(90,433) | $10,617 | $98,548 | $45,015 | $36,322 |
| (Loss) earnings per share |  |  |  |  |  |
| Basic | $(1.14) | $0.14 | $1.27 | $0.59 | $0.47 |
| Diluted | $(1.14) | $0.13 | $1.19 | $0.56 | $0.46 |
| Cash dividends declared per common share | $0.12 | $0.12 | $0.12 | $0.12 | $0.12 |



## Text

ITEM 6. SELECTED FINANCIAL DATA


The selected financial data presented below has been derived from our audited consolidated financial statements. This data should be read in conjunction with “Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations” and “Item 8. Financial Statements and Supplementary Data” of this Annual Report.


(1) We elected to early adopt Accounting Standards Update (“ASU”) 2016-09 “Compensation - Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting” (“ASU 2016-09”) in 2016, which requires us, among other things, to prospectively record excess tax benefits as a reduction of the provision for income taxes in the consolidated statement of operations, whereas they were previously recognized in equity.


(2) We retrospectively adopted ASU 2014-09, “Revenue from Contracts with Customers (Topic 606)” in 2018. As a result, we have adjusted balances for 2017 and 2016. We have not adjusted 2015 for ASU 2014-09.
## Table

|  | Service-based RSUs Outstanding |  | Market-based RSUs Outstanding |  |
|---|---|---|---|---|
|  | Number of Shares | Weighted-Average Grant Date Fair Value | Number of Shares | Weighted-Average Grant Date Fair Value |
| June 26, 2016 | 3,256,513 | $71.34 | 1,078,591 | $63.12 |
| Granted | 1,224,877 | $114.13 | 435,694 | $111.75 |
| Vested | (1,677,318) | $69.10 | (592,321) | $46.67 |
| Forfeited or canceled | (116,466) | $76.76 | (59,509) | $66.81 |
| June 25, 2017 | 2,687,606 | $92.01 | 862,455 | $83.83 |
| Granted | 964,391 | $183.97 | 285,866 | $170.15 |
| Vested | (1,362,369) | $87.80 | (407,024) | $76.88 |
| Forfeited or canceled | (96,540) | $108.67 | (47,571) | $91.36 |
| June 24, 2018 | 2,193,088 | $134.34 | 693,726 | $104.59 |
| Granted | 893,622 | $161.64 | 163,529 | $165.78 |
| Vested | (1,135,284) | $115.23 | (301,622) | $70.58 |
| Forfeited or canceled | (154,541) | $141.38 | (120,859) | $104.73 |
| June 30, 2019 | 1,796,885 | $159.36 | 434,774 | $144.57 |



## Text

Restricted Stock Units


During the fiscal years 2019, 2018, and 2017, the Company issued both service-based RSUs and market-based performance RSUs (“PRSUs”). Market-based PRSUs generally vest three years from the grant date if certain performance criteria are achieved and require continued employment. Based upon the terms of such awards, the number of shares that can be earned over the performance periods is based on the Company’s Common Stock price performance compared to the market price performance of the Philadelphia Semiconductor Sector Index (“SOX”), ranging from 0% to 150% of target. The stock price performance or market price performance is measured using the closing price for the 50-trading days prior to the dates the performance period begins and ends. The target number of shares represented by the market-based PRSUs is increased by 2% of target for each 1% that Common Stock price performance exceeds the market price performance of the SOX index. The result of the vesting formula is rounded down to the nearest whole number. Total stockholder return is a measure of stock price appreciation in this performance period.


The following table summarizes restricted stock activity:


The fair value of the Company’s service-based RSUs was calculated based on fair market value of the Company’s stock at the date of grant, discounted for dividends.
## Table

| For the Years Ended December 31, |  |  |  |  |
|---|---|---|---|---|
|  | 2019 | 2018 | Change | % Change |
| (In millions, except percentages) |  |  |  |  |
| Revenues | $13.2 | $82.3 | $(69.1) | (84)% |
| Cost of revenues | 1.9 | 15.3 | (13.4) | (88)% |
| Gross profit | 11.3 | 67.0 | (55.7) | (83)% |
| Gross margin | 86 % | 81 % |  |  |
| Operating expenses: |  |  |  |  |
| Selling, general and administrative | 31.7 | 32.2 | (0.5) | (2)% |
| Research and development | 2.0 | 2.1 | (0.1) | (5)% |
| Total operating expenses | 33.7 | 34.3 | (0.6) | (2)% |
| Other expense | (0.3) | (4.0) | 3.7 | (93)% |
| Income (loss) before income taxes | (22.7) | 28.7 | (51.4) | (179)% |
| Income tax provision (benefit) | (6.2) | 8.0 | (14.2) | (178)% |
| Net income (loss) | $(16.5) | $20.7 | $(37.2) | (180)% |



## Text

Year ended December 31, 2019 compared with the year ended December 31, 2018:


Revenue in 2019 is derived from license agreements that we entered into with third-parties following negotiations pursuant to our patent licensing and enforcement program. The revenue decrease is primarily due to timing of revenues, as further described in "Item 1. Business" - "Licensing and Enforcement - Current Activities, Post 2013".


Cost of revenues includes contingent legal fees directly associated with our licensing and enforcement programs. Cost of revenues primarily decreased in proportion to the decrease in revenues.


Operating expenses consists of sales and marketing, general and administrative, and research and development. Selling, general and administrative expenses ("SG&A") consisted primarily of legal fees incurred in operations and employee headcount related expenses. These comprise approximately 60% of total SG&A expense. Litigation expenses increased $3.0 million to $19.4 million in 2019 compared to 2018 and are primarily due to the timing of various outstanding litigation actions. See "Item 3. Legal Proceedings". Employee headcount related expenses decreased $2.0 million to $3.6 million in 2019 compared to 2018, primarily due to lower incentive bonuses.


Research and development expense remained flat between years.


Other expense decreased in 2019 as we no longer have exposure from the warrant liability, and included $0.7 million related to the sale of our investment in JVP, offset by $0.3 million of net interest income.


Income tax provision (benefit) is primarily a function of income (loss) before income, state income tax expense (benefit) and federal benefit of foreign derived intangible tax benefit related to 2018.
## Table

|  |  | Year Ended March 31, |  |
|---|---|---|---|
|  | 2019 | 2018 | 2017 |
| Net income from continuing operations | $355.9 | $255.4 | $170.6 |
| Basic weighted average common shares outstanding | 236.2 | 232.9 | 217.2 |
| Dilutive effect of stock options and RSUs | 3.8 | 4.4 | 4.4 |
| Dilutive effect of 2007 Junior Convertible Debt | — | 1.3 | 12.7 |
| Dilutive effect of 2015 Senior Convertible Debt | 9.9 | 10.3 | 0.5 |
| Dilutive effect of 2017 Senior Convertible Debt | — | — | — |
| Dilutive effect of 2017 Junior Convertible Debt | — | — | — |
| Diluted weighted average common shares outstanding | 249.9 | 248.9 | 234.8 |
| Basic net income per common share from continuing operations | $1.51 | $1.10 | $0.79 |
| Diluted net income per common share from continuing operations | $1.42 | $1.03 | $0.73 |



## Text

Note 20. Net Income Per Common Share From Continuing Operations


The following table sets forth the computation of basic and diluted net income per common share from continuing operations (in millions, except per share amounts):


The Company computed basic net income per common share from continuing operations based on the weighted average number of common shares outstanding during the period. The Company computed diluted net income per common share from continuing operations based on the weighted average number of common shares outstanding plus potentially dilutive common shares outstanding during the period.


Potentially dilutive common shares from employee equity incentive plans are determined by applying the treasury stock method to the assumed exercise of outstanding stock options and the assumed vesting of outstanding RSUs. Weighted average common shares exclude the effect of option shares which are not dilutive. There were no anti-dilutive option shares for the years ended March 31, 2019, 2018, and 2017.
## Table

| December 31, 2019 |  |  |  |  |
|---|---|---|---|---|
|  | Level 1 | Level 2 | Level 3 | Total |
| Assets: |  |  |  |  |
| Money market funds | $107,708 | $— | $— | $107,708 |
| U.S. government agencies | — | 77,364 | — | 77,364 |
| Corporate debt securities | — | 207,137 | — | 207,137 |
| Total | $107,708 | $284,501 | $— | $392,209 |
| Liabilities: |  |  |  |  |
| Contingent consideration | $— | $— | $1,889 | $1,889 |
| Derivative liabilities | — | 748 | — | 748 |
| Total | $— | $748 | $1,889 | $2,637 |
|  |  |  |  |  |
| December 31, 2018 |  |  |  |  |
|  | Level 1 | Level 2 | Level 3 | Total |
| Assets: |  |  |  |  |
| Money market funds | $273,546 | $— | $— | $273,546 |
| U.S. government agencies | — | 72,840 | — | 72,840 |
| Corporate debt securities | — | 228,953 | — | 228,953 |
| Derivative assets | — | 623 | — | 623 |
| Total | $273,546 | $302,416 | $— | $575,962 |
| Liabilities: |  |  |  |  |
| Derivative liabilities | $— | $549 | $— | $549 |
| Stock warrant liability | — | — | 410 | 410 |
| Total | $— | $549 | $410 | $959 |



## Text

Fair Value Measurement of Financial Assets and Liabilities


The carrying values of the Company’s accounts receivable and accounts payable, approximated their fair values due to the short period of time to maturity or repayment.


The following tables set forth the Company’s financial instruments that were measured at fair value on a recurring basis by level within the fair value hierarchy (in thousands):


The fair value of the Company’s Level 1 financial instruments is based on quoted market prices in active markets for identical instruments. The fair value of the Company’s Level 2 financial instruments is based on observable inputs other than quoted prices in active markets for identical assets and liabilities, quoted prices for identical or similar assets or liabilities in inactive markets, or other inputs that are observable or can be corroborated by observable market data.


In addition, Level 2 assets and liabilities include derivative financial instruments associated with hedging activity, which are further discussed in Note 4. Derivative financial instruments are initially measured at fair value on the contract date and are subsequently remeasured to fair value at each reporting date using inputs such as spot rates, forward rates, and discount rates. There is not an active market for each hedge contract, but the inputs used to calculate the value of the instruments are tied to active markets.
## Table

|  |  | For the Year Ended |  |
|---|---|---|---|
|  | January 31, 2020 | February 1, 2019 | February 2, 2018 |
| Federal: |  |  |  |
| Current | $78 | $181 | $688 |
| Deferred | (219) | (92) | 275 |
|  | (141) | 89 | 963 |
| State: |  |  |  |
| Current | 45 | 31 | 8 |
| Deferred | (44) | (10) | 21 |
|  | 1 | 21 | 29 |
| Foreign: |  |  |  |
| Current | 240 | 137 | 156 |
| Deferred | (5,018) | (8) | 4 |
|  | (4,778) | 129 | 160 |
| Total income tax provision (benefit) | $(4,918) | $239 | $1,152 |



## Text

P. Income Taxes


VMware’s income tax provision (benefit) for the periods presented consisted of the following (table in millions):
## Table

| ($ in millions) |  |  |  |
|---|---|---|---|
| For the year ended December 31: | 2019 | 2018 | Yr.-to-Yr. Percent Change |
| Other (income) and expense |  |  |  |
| Foreign currency transaction losses/(gains) | $(279) | $(427) | (34.6)% |
| (Gains)/losses on derivative instruments | 15 | 434 | (96.6) |
| Interest income | (349) | (264) | 32.2 |
| Net (gains)/losses from securities and investment assets | (32) | (101) | (67.9) |
| Retirement-related costs/(income) | 615 | 1,572 | (60.9) |
| Other | (937) | (63) | NM |
| Total consolidated other (income) and expense | $(968) | $1,152 | NM |
| Non-operating adjustments |  |  |  |
| Amortization of acquired intangible assets | (2) | (2) | 50.0% |
| Acquisition-related charges | 154 | 0 | NM |
| Non-operating retirement related costs/(income) | (615) | (1,572) | (60.9)% |
| Operating (non-GAAP) other (income) and expense | $(1,431) | $(422) | 239.4% |



## Text

Other (Income) and Expense


NM—Not meaningful


Total consolidated other (income) and expense was income of $968 million in 2019 compared to expense of $1,152 million in 2018. The year-to-year change was primarily driven by: • Lower non-operating retirement-related costs ($957 million). Refer to “Retirement-Related Plans” for additional information. • Higher gains from divestitures ($833 million) reflected in Other; and • Higher net exchange gains (including derivative instruments) ($272 million). The company’s hedging programs help mitigate currency impacts in the Consolidated Income Statement.


Operating (non-GAAP) other (income) and expense was $1,431 million of income in 2019 and increased $1,010 million compared to the prior-year period. The year-to-year change was primarily driven by the same factors excluding lower non-operating retirement-related costs.
## Table

|  |  | Fiscal Years Ended March 31, |  |
|---|---|---|---|
|  | 2019 | 2018 | 2017 |
| Current: |  |  |  |
| Federal | $170 | $223 | $— |
| State and local | 161 | 50 | 62 |
| Foreign | 9,966 | 8,295 | 4,247 |
| Total current income tax expense from continuing operations | 10,297 | 8,568 | 4,309 |
| Deferred: |  |  |  |
| Federal | (43,804) | (807) | (6) |
| State and local | (773) | (96) | (97) |
| Foreign (1) | (5,180) | 1,467 | 88 |
| Deferred tax expense (benefit) from continuing operations (1) | (49,757) | 564 | (15) |
| Provision for income tax expense (benefit) (1) | $(39,460) | $9,132 | $4,294 |



## Text

Note 11: Income Taxes


The provision for income tax expense (benefit) is as follows (amounts in thousands):


(1) Fiscal years ended March 31, 2018 and 2017 adjusted due to the adoption of ASC 606.


The Company realized a deferred tax expense (benefit) for fiscal years ended 2019, 2018 and 2017 of ($50.1) million, $0.6 million and $1.2 million, respectively, in U.S. and certain foreign jurisdictions based on changes in judgment about the realizability of deferred tax assets in future years.